The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Trends in Incidence Rates of Invasive Lobular and Ductal Breast Carcinoma
Open accessAbstract
CONTEXT: Research has suggested that use of combined estrogen and progestin hormone replacement therapy (CHRT) increases breast cancer risk and that CHRT use is more strongly associated with the risk of invasive lobular breast carcinoma than that of invasive ductal carcinoma. Lobular carcinoma is less common than ductal carcinoma but can be more difficult to diagnose because of its subtle elusive infiltrative pattern. OBJECTIVE: To evaluate trends in invasive lobular and ductal carcinoma incidence rates from 1987 through 1999, during which time use of CHRT increased in the United States. DESIGN: Descriptive epidemiologic study. SETTING: Nine cancer registries that participate in the Surveillance, Epidemiology, and End Results (SEER) program of the National Cancer Institute and that cover Atlanta, Ga; Detroit, Mich; San Francisco-Oakland, Calif; Seattle, Wash; and Connecticut, Hawaii, Iowa, New Mexico, and Utah. POPULATION: Women 30 years of age and older residing in the areas covered by the 9 SEER registries. MAIN OUTCOME MEASURES: Proportional changes in incidence rates of invasive lobular and ductal carcinoma among women with no prior history of breast cancer. RESULTS: A total of 190 458 women were included in this analysis who were identified through the registries as having invasive breast cancer; 7682 of the 198 140 potentially eligible women (ie, those identified as not having in situ breast cancer) were excluded from this analysis because stage of cancer was unknown. Invasive breast cancer incidence rates adjusted for age and for SEER historic stage increased 1.04-fold (95% confidence interval [CI], 1.004-1.07) from 1987-1999 (206.7/100 000 to 214.1/100 000, age-adjusted). However, incidence rates of tumors classified as lobular increased 1.52-fold (95% CI, 1.42-1.63), and those classified as mixed ductal-lobular increased 1.96-fold (95% CI, 1.80-2.14); rates of these types combined increased 1.65-fold (95% CI, 1.55-1.78) (19.8/100 000 to 33.4/100 000, age-adjusted). In contrast, ductal carcinoma rates remained largely constant (153.8/100 000 to 155.3/100 000, age-adjusted; proportional change, 1.03 [95% CI, 0.99-1.06]). The proportion of breast cancers with a lobular component increased from 9.5% in 1987 to 15.6% in 1999. CONCLUSIONS: Ductal carcinoma incidence rates remained essentially constant from 1987-1999 while lobular carcinoma rates increased steadily. This increase presents a clinical challenge given that lobular carcinoma is more difficult to detect than ductal carcinoma by both physical examination and mammography.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Gardner, W. P., Mulvey, E. P., & Shaw, E. C. (1995) · Psychological Bulletin · doi:10.1037//0033-2909.118.3.392 · Cited by 1,836
(2006) · Cancer · doi:10.1002/(issn)1097-0142 · Cited by 1,470
Hormone Replacement Therapy in Relation to Breast Cancer
Chen, C.-L. (2002) · JAMA · doi:10.1001/jama.287.6.734 · Cited by 360
A Case-Control Study of Menopausal Estrogen Therapy and Breast Cancer
Ross, R. K. (1980) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1980.03300420019018 · Cited by 254
Brett, K. M., & Madans, J. H. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009142 · Cited by 241
Infiltrating lobular carcinoma of the breast
Dixon, J. M., Anderson, T. J., Page, D. L., Lee, D., & Duffy, S. W. (1982) · Histopathology · doi:10.1111/j.1365-2559.1982.tb02712.x · Cited by 227
Use of Menopausal Estrogens and Medroxyprogesterone in the United States, 1982-1992
Wysowski, D. (1995) · Obstetrics & Gynecology · doi:10.1016/0029-7844(94)00339-f · Cited by 193
Postmenopausal estrogen and progestin use in relation to breast cancer risk.
Newcomb, P. A., Titus-Ernstoff, L. T., Egan, K. M., Trentham‐Dietz, A., Baron, J. A., Storer, B. E., Willett, W. C., & Stampfer, M. J. (2002) · PubMed · Cited by 182
Cited by
Berg, W. A., Gutierrez, L., NessAiver, M. S., Carter, W. B., Bhargavan, M., Lewis, R. S., & Ioffe, O. B. (2004) · Radiology · doi:10.1148/radiol.2333031484 · Cited by 1,439
Clinical characteristics of different histologic types of breast cancer
Li, C. I., Uribe, D. J., & Daling, J. R. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602787 · Cited by 598
Self-citationMDM2 SNP309 accelerates tumor formation in a gender-specific and hormone-dependent manner
Bond, G. L., Hirshfield, K. M., Kirchhoff, T., Alexe, G., Bond, E. E., Robins, H., Bartel, F., Taubert, H., Wuerl, P., Hait, W., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0180 · Cited by 287
Fertility Preservation in Young Women Undergoing Breast Cancer Therapy
Sonmezer, M., & Oktay, K. (2006) · The Oncologist · doi:10.1634/theoncologist.11-5-422 · Cited by 261
Fackler, M. J., McVeigh, M., Evron, E., Garrett, E., Mehrotra, J., Polyak, K., Sukumar, S., & Argani, P. (2003) · International Journal of Cancer · doi:10.1002/ijc.11508 · Cited by 253
Metadata
- Authors
- Li, C. I., Anderson, B. O., Daling, J. R., & Moe, R. E.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2003-03-19
- Volume
- 289
- Issue
- 11
- Pages
- 1421
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2062444881
- Cited by
- 577
- References
- 15
- FWCI
- 9.41
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Trends in Incidence Rates of Invasive Lobular and Ductal Breast Carcinoma. https://app.cochat.ai/papers/10.1001/jama.289.11.1421
- The paper
- Li, C. I., Anderson, B. O., Daling, J. R., & Moe, R. E. (2003). Trends in Incidence Rates of Invasive Lobular and Ductal Breast Carcinoma. JAMA. https://doi.org/10.1001/jama.289.11.1421
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.